Cargando…
Retraction Note: Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma
Autores principales: | Qin, Yan-Guo, Zhu, Lan-Yu, Wang, Chen-Yu, Zhang, Bo-Yan, Wang, Qing-Yu, Li, Rui-Yan, Liu, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702685/ https://www.ncbi.nlm.nih.gov/pubmed/33256742 http://dx.doi.org/10.1186/s12944-020-01416-2 |
Ejemplares similares
-
Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma
por: Qin, Yan-Guo, et al.
Publicado: (2015) -
Retinoic acid-incorporated glycol chitosan nanoparticles inhibit the expression of Ezh2 in U118 and U138 human glioma cells
por: LU, HU-CHEN, et al.
Publicado: (2016) -
Retraction Note: Establishing an osteosarcoma associated protein-protein interaction network to explore the pathogenesis of osteosarcoma
por: Deng, Bi-Yong, et al.
Publicado: (2015) -
Retraction Note to: A Comparative Study of the Toxicity of Polyethylene Glycol–Coated Cobalt Ferrite Nanospheres and Nanoparticles
por: Akhtar, Shahnaz, et al.
Publicado: (2020) -
Retraction Note: LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p
por: Wang, Zhen, et al.
Publicado: (2023)